Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOWOL study of reduced-volume bowel preparation products for screening colonoscopy
2019-003186-18Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Dec 2019
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of macrogol and citric acid in colorectal cancer (CRC) (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Adverse reaction to the product. Started Dec 2019; status: completed.
02
Drugs
macrogolcitric acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2019-003186-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003186-18.